629 related articles for article (PubMed ID: 32289347)
21. Synergistic effect of endurance training and nettle leaf extract on the IDO1-KYN-AHR pathway homeostasis and inhibiting of liver toxicity in rats with STZ-induced diabetes.
Haghshenas R; Aftabi Y; Doaei S; Gholamalizadeh M
Front Endocrinol (Lausanne); 2023; 14():1071424. PubMed ID: 37305057
[TBL] [Abstract][Full Text] [Related]
22. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
23. Amyloid β neurotoxicity is IDO1-Kyn-AhR dependent and blocked by IDO1 inhibitor.
Duan Z; Zhang S; Liang H; Xing Z; Guo L; Shi L; Du L; Kuang C; Takikawa O; Yang Q
Signal Transduct Target Ther; 2020 Jun; 5(1):96. PubMed ID: 32532956
[No Abstract] [Full Text] [Related]
24. Indoleamine 2,3-dioxygenase gene expression and kynurenine to tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival.
Souissi S; Ghedira R; Macherki Y; Ben-Haj-Ayed A; Gabbouj S; Remadi Y; Sfar I; Chadli Z; Aouam K; Hassine M; Bouaouina N; Zakhama A; Hassen E
Immun Inflamm Dis; 2022 Sep; 10(9):e690. PubMed ID: 36039641
[TBL] [Abstract][Full Text] [Related]
25. Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling.
Chen CT; Wu PH; Hu CC; Nien HC; Wang JT; Sheu JC; Chow LP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769098
[TBL] [Abstract][Full Text] [Related]
26. The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice.
Ogiso H; Ito H; Ando T; Arioka Y; Kanbe A; Ando K; Ishikawa T; Saito K; Hara A; Moriwaki H; Shimizu M; Seishima M
PLoS One; 2016; 11(9):e0162183. PubMed ID: 27598994
[TBL] [Abstract][Full Text] [Related]
27. Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
Alvarado DM; Chen B; Iticovici M; Thaker AI; Dai N; VanDussen KL; Shaikh N; Lim CK; Guillemin GJ; Tarr PI; Ciorba MA
Gastroenterology; 2019 Oct; 157(4):1093-1108.e11. PubMed ID: 31325428
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-Inducible Factor 1α (HIF1α) Suppresses Virus Replication in Human Cytomegalovirus Infection by Limiting Kynurenine Synthesis.
Wise LM; Xi Y; Purdy JG
mBio; 2021 Mar; 12(2):. PubMed ID: 33758082
[TBL] [Abstract][Full Text] [Related]
29. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
[TBL] [Abstract][Full Text] [Related]
30. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy.
Wang Y; Song J; Yu K; Nie D; Zhao C; Jiao L; Wang Z; Zhou L; Wang F; Yu Q; Zhang S; Wen Z; Wu J; Wang CY; Wang DW; Cheng J; Zhao C
Hypertension; 2023 Oct; 80(10):2099-2111. PubMed ID: 37485661
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
[TBL] [Abstract][Full Text] [Related]
32. Quantification of IDO1 enzyme activity in normal and malignant tissues.
Zhai L; Ladomersky E; Bell A; Dussold C; Cardoza K; Qian J; Lauing KL; Wainwright DA
Methods Enzymol; 2019; 629():235-256. PubMed ID: 31727243
[TBL] [Abstract][Full Text] [Related]
33. Tryptophan and kynurenine stimulate human decidualization via activating Aryl hydrocarbon receptor: Short title: Kynurenine action on human decidualization.
Wang PC; Chen ST; Hong ZK; Li SY; Yang ZS; Quan S; Yang ZM
Reprod Toxicol; 2020 Sep; 96():282-292. PubMed ID: 32781018
[TBL] [Abstract][Full Text] [Related]
34. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
35. Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer.
Kado SY; Bein K; Castaneda AR; Pouraryan AA; Garrity N; Ishihara Y; Rossi A; Haarmann-Stemmann T; Sweeney CA; Vogel CFA
Cells; 2023 May; 12(10):. PubMed ID: 37408267
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis.
Kolodziej L
Transgenic Res; 2013 Oct; 22(5):1049-54. PubMed ID: 23417792
[TBL] [Abstract][Full Text] [Related]
37. Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis.
Kim CE; Lee SM; Yoon EH; Won HJ; Jung YJ; Jegal Y; Kim DH; Kwon B; Seo SK
Int Immunopharmacol; 2024 Jun; 134():112246. PubMed ID: 38759372
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
39. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.
Vogel CF; Goth SR; Dong B; Pessah IN; Matsumura F
Biochem Biophys Res Commun; 2008 Oct; 375(3):331-5. PubMed ID: 18694728
[TBL] [Abstract][Full Text] [Related]
40. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
